Here, the functional consequences of USP22 on PML expression levels were investigated by CRISPR/Cas9-mediated constitutive knock-out (KO) of USP22 in the human HT-29 colon carcinoma cell line, generated as described previously [37]. Here, USP22 is linked to colon carcinoma.